Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10064714 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2005 | 5 Pages |
Abstract
This study did not show any advantage in efficacy or compliance with oxybutynin when two different regimens of low starting were used. Two-thirds of patients discontinued the therapy within 4-6 months. Therefore, patients on anticholinergics should be reassessed after 6 months in clinical practice.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Stefano Salvatore, Vikram Khullar, Linda Cardozo, Rodolfo Milani, Stavros Athanasiou, Con Kelleher,